Skip to main content
Medical information Clinical review pending

Genetic Testing

GATA3 Gene Hypoparathyroidism Sensorineural Deafness and Renal Dysplasia Genetic Test

This genetic test analyzes the GATA3 gene to identify mutations linked to hypoparathyroidism, sensorineural deafness, and renal dysplasia. It uses Next-Generation Sequencing (NGS) technology for accurate results.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube), Extracted DNA, or One drop of blood on FTA Card.
Results
Confirm with the laboratory before booking.
Preparation
Provide a detailed clinical history. Genetic counseling is recommended prior to testing.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the GATA3 Gene Hypoparathyroidism Sensorineural Deafness and Renal Dysplasia Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Unexplained hypoparathyroidism
  • ✓Sensorineural deafness
  • ✓Renal dysplasia or abnormalities
  • ✓Family history of GATA3-related disorders
  • ✓Genetic counseling for related conditions
02

In plain language

What this test helps you understand

Identifies mutations in the GATA3 gene associated with hypoparathyroidism, sensorineural deafness, and renal dysplasia, aiding in diagnosis and management.
The GATA3 Gene Hypoparathyroidism Sensorineural Deafness and Renal Dysplasia NGS Genetic DNA Test is an advanced diagnostic tool used to identify genetic mutations associated with specific health conditions. This test is particularly relevant for individuals showing signs or symptoms related to the GATA3 gene, such as hypoparathyroidism, sensorineural deafness, or renal dysplasia. By employing Next-Generation Sequencing (NGS) technology, we aim to provide precise and comprehensive results to support clinical decision-making.

This genetic test focuses specifically on the GATA3 gene, looking for variations that may cause hypoparathyroidism, sensorineural deafness, and renal dysplasia. The information gained from this test can be crucial for early diagnosis and effective management of these conditions.

Individuals experiencing symptoms like unexplained hypoparathyroidism, hearing loss or sensorineural deafness, or renal abnormalities might benefit from this test. Additionally, individuals with a family history of these conditions or known GATA3 gene mutations are encouraged to consider genetic testing.

Taking this test offers several advantages, including the potential for early detection of genetic disorders, guidance for clinical management and treatment planning, and a better understanding of familial risk, which can inform genetic counseling.

Results will be provided along with general interpretation guidance. It is important to discuss your results with a healthcare professional to fully understand their implications and discuss any necessary next steps.

Sample collection involves a blood draw, extracted DNA, or a single drop of blood on an FTA card. A clinical history of the patient is essential before the test. Genetic counseling is recommended, especially to create a family pedigree chart if relevant.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationProvide a detailed clinical history. Genetic counseling is recommended prior to testing.
SampleBlood sample (EDTA tube), Extracted DNA, or One drop of blood on FTA Card.
MethodologyNext-Generation Sequencing (NGS) of the GATA3 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific regions of the GATA3 gene. It may not detect all possible mutations, such as deep intronic changes or large deletions/duplications not detectable by NGS. Results must be interpreted alongside clinical findings.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test helps identify genetic mutations in the GATA3 gene linked to hypoparathyroidism, sensorineural deafness, and renal dysplasia.
Individuals with symptoms like unexplained hypoparathyroidism, hearing loss, or renal abnormalities, or those with a family history of these conditions, should consider this test.
A blood sample, extracted DNA, or a single drop of blood on an FTA card is required.
Turnaround time varies. Please confirm the current timeframe with the laboratory before booking.
Yes, genetic counseling is recommended before the test to discuss the implications and understand the results better.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp